I’ve been thinking about this for a while.
There’s a lot of talk about psilocybin right now. Some of it is good science. Some of it is marketing. Too much of it tells people what they should feel, instead of asking what they actually felt.
That’s how Entourage started.
At Serenite we spend a lot of time on chemistry and testing. Useful work. But the more interesting material was sitting next to it the whole time: our customers already had the story, so we built a system to query verified customers describing their own experience in their own words.
Emotional tone. Cognitive energy. Body energy. And the language itself — because the words are often the most honest part.
Here is what we’ve been told over the last 60 days:
We’re past 80 verified observations now. That is not a study, but it will become the foundation which medical researchers might lean on when they want to understand the various benefits of microdosing. In our customers own words. Not mine.
We’re starting to see recurring language. Differences between mushrooms. And early ways to set those notes next to what we measure in the lab.
I don’t know what all of it means yet. That’s the part I like.
I’ve built businesses long enough to know how easy it is to fall in love with a good story. I’d rather build something that can prove me wrong.
So Entourage isn’t a proof engine. It isn’t testimonials in a lab coat. It isn’t a promise about your next experience. It’s an attempt to listen carefully, consistently, and see what holds up.
That’s why I’m starting on Substack. I’ll share what we’re learning — observations, chemistry, research worth reading, and conversations with people who take this seriously. Some of it will fit what I expected. Some of it won’t.
Our pure single strain small batch microdose mushrooms provide a fascinating foundation to learn which chemicals in mushrooms help actual users achieve specific desired outcomes. This isn’t a sales pitch. It’s an invitation to learn alongside us.
We could have chosen to synthesize a few molecules surrounding psilocybin, hope that we got it right, invite a few hundred people to join a study to prove if we were, or were not. The traditional pharmacological research may not tell the whole story.
Personally, I think there is an entourage effect when various other secondary metabolites in psilocybin mushrooms combine. The outcome may lead us to a mushroom chemical profile that supports “mood lift”, or another mushroom may lead to “calm mind calm body” and yet another may prove useful for alcohol avoidance. It’s still too early to tell, but the feedback we’ve received so far is beginning to tell this story. That’s why we are overlaying people’s experience with third-party certified COA lab results. Because we think clear connections will emerge. And we also think this may help us to make sure that when a customer is looking for access that they experience what they came for and more importantly, they don’t experience what they’re not looking for.
I don’t think we need more people telling us what to think about mushrooms. We need more people paying attention to what is actually happening.
That’s the work I’m doing with Serenite. It is a wonder to watch Entourage evolve, and a blessing to not be trying to prove anything.
I think it’s fundamentally good work.
